The Methuselah Gene

Biotech is big business. Now a giant called Celgene is investing in biotech’s future by buying Impact BioMedicines with a $7 Billion ante up. Good investment? Well, biobucks are hotter than Bitcoin, long term. More money than opioids. Just watch any network news report, the second half of which is all pharmaceuticals, with side effects. Development takes years and billions, and the payoffs are big, and losses also. (My sister has cancer, and her meds just on insurance co-pay were $500 a week. Didn’t help. Now she’s on Hospice.) Drug patents expire, rivals vie for space, with mergers and acquisitions the ultimate power play. Congress is trying to deregulate everything from the EPA to the DEA. It’s a “go big or go home” strategy. The cancer drug Jakafi is a huge seller for two other pharmaceutical giants, and Celgene wants to compete. They want in, and are into Immunotherapy too. On the ropes with their own drug expiring soon, they have little choice. The CEO touts the future of using genetic engineering to attach genes to molecules, similar to what Ron Howard’s show Breakthroughs reported a year or so ago in which a neutered HIV targeted cancers past the blood/brain barrier.  Meanwhile, supplements like Nugenix is being hyped to athletes to improve testosterone. Is there a dark side to biotech? “CRISPR” (pronounced “crisper”) stands for Clustered Regularly Interspaced Short Palindromic Repeats, which are the hallmark of a bacterial defense system that forms the basis for CRISPR-Cas9 genome editing technology. It may soon be possible to eliminate certain diseases genetically, to change the eye color (and more) of babies, and to lengthen the lifespan of humans. Many strides have already been made, such as the means to fight cancer using gene therapy. To some, this is all “playing God,” while to others it is progress: the “search for better explanations, leading to discoveries,” as David Deutsch put it in “The Beginning of Infinity.” Whatever the technology, there are problems, as discussed in the book on social media interfaces: “Dawn of the New Everything” by Jaron Lanier. In my novel “The Methuselah Gene” a neutered HIV is used, not as a cancer therapy, but to implant a longevity gene taken from a bristlecone pine tree past the blood/brain barrier, and extend human life by decades. A pill to do something like this is now in the works, and may be here within a decade. How much would such a pill cost, and will only the super rich be able to afford it? In the New Rules governing culture, before young icons can imagine near immortality via science, what if nefarious forces tested it on a small town without their knowledge or consent…and discovered that there were side effects?

Jonathan Lowe

 

Advertisements